Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Are Antidepressants Safe and Effective in Children?

20.12.2005


Neuroscientist Takes Issue with Antidepressants for Children



The question of whether SSRI antidepressants, such as fluoxetine (Prozac), are safe and more effective than dummy pills for treating child and adolescent depression (CAD) remains highly contentious, says Dr Amir Raz, Assistant Professor of Clinical Neuroscience in the Division of Child and Adolescent Psychiatry at Columbia University and Research Scientist at the New York State Psychiatric Institute, in New York City.

Writing in the open access journal PLoS Medicine, Dr Raz says that when it comes to treating CAD, “there are few compelling data sets, free of funding from drug companies, concerning the efficacy of antidepressant medications over and above their placebo value.”


In his analysis, Dr Raz looks at some of the reasons behind the current dispute over the value of SSRI antidepressants for treating depressed children and adolescents.

“The recent history of SSRIs is replete with inconsistent verdicts about their safety,” he says. For example, despite issuing a “black box” warning label on antidepressants stating that they may increase the risk of suicidal thinking and behavior in depressed children and adolescents, the FDA went on to endorse the safety of these drugs for treating CAD.

In addressing possible implications of SSRI use for CAD, Dr Raz points to data in mouse studies suggesting that exposure to SSRIs early in life produces abnormal emotional behaviors in adults. “Some exploratory findings suggest that artificial perturbation of serotonin function in early life may alter the normal development of brain systems related to stress, motor development, and motor control.”

Another factor, says Dr Raz, that further confounds the debate over SSRIs for CAD is that while some studies have shown statistically significant effects, these effects may not be meaningful in the real world of clinical practice. Dr Irving Kirsch and Dr David Antonuccio, who gave testimony to the FDA in 2004 on the efficacy of SSRIs for CAD, also concluded that the effect of these drugs may be statistically significant, but possibly not clinically significant.

Dr Raz says that while some mental health experts “dismiss investigators such as Kirsch and Antonuccio as ‘outliers’ or inherently biased against the drug industry, such ‘outlying’ accounts should nevertheless be examined.”

Given all of the limitations surrounding the data on SSRIs, Dr Raz urges patients and physicians to “demand stronger evidence for the efficacy of antidepressants for CAD.”

Paul Ocampo | alfa
Further information:
http://www.plos.org
http://www.plosmedicine.org

More articles from Health and Medicine:

nachricht Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University

nachricht Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

New pop-up strategy inspired by cuts, not folds

27.02.2017 | Materials Sciences

Sandia uses confined nanoparticles to improve hydrogen storage materials performance

27.02.2017 | Interdisciplinary Research

Decoding the genome's cryptic language

27.02.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>